GET THE APP

Acquired Immunodeficiency Syndrome (AIDS): A Comprehensive Overview
..

Journal of Health & Medical Informatics

ISSN: 2157-7420

Open Access

Mini Review - (2023) Volume 14, Issue 3

Acquired Immunodeficiency Syndrome (AIDS): A Comprehensive Overview

James Gideon*
*Correspondence: James Gideon, Department of Endocrinology, University of Victoria, Victoria, Canada, Email:
Department of Endocrinology, University of Victoria, Victoria, Canada

Received: 01-May-2023, Manuscript No. jhmi-23-103486; Editor assigned: 03-May-2023, Pre QC No. P-103486; Reviewed: 15-May-2023, QC No. Q-103486; Revised: 20-May-2023, Manuscript No. R-103486; Published: 27-May-2023 , DOI: 10.37421/2157-7420.2023.14.473
Citation: Gideon, James. “Acquired Immunodeficiency Syndrome (AIDS): A Comprehensive Overview.” Int J Health Med Informat 14 (2023): 473.
Copyright: © 2023 Gideon J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Acquired Immunodeficiency Syndrome (AIDS) remains a significant global health issue despite advancements in medical research and public health efforts. This comprehensive article aims to provide an in-depth understanding of AIDS, covering its history, causes, transmission, symptoms, diagnosis, treatment, prevention, and global impact. By exploring these aspects, we can enhance awareness and knowledge about AIDS and work towards eradicating this devastating disease.

Keywords

Acquired Immunodeficiency Syndrome (AIDS) • HIV • Pandemic

Introduction

Acquired Immunodeficiency Syndrome (AIDS) is a complex and progressive disease caused by the Human Immunodeficiency Virus (HIV). AIDS has since become a global pandemic affecting millions of individuals worldwide. Despite significant progress in treatment and prevention, AIDS continues to pose serious challenges to public health systems, especially in low- and middle-income countries. The history of AIDS dates back to the late when unusual cases of severe immune deficiency were observed in several individuals. The identification of HIV as the causative agent of AIDS revolutionized the understanding of the disease. Since then, extensive research has been conducted to elucidate the virus's characteristics, transmission routes, and the progression of the disease. HIV is primarily transmitted through specific body fluids, including blood, semen, vaginal secretions, and breast milk. The most common modes of transmission are unprotected sexual intercourse, sharing contaminated needles or syringes, mother-to-child transmission during childbirth or breastfeeding, and less commonly, through blood transfusions or organ transplantation [1].

HIV targets and attacks CD4+ T cells, a vital component of the immune system responsible for coordinating immune responses. The virus progressively weakens the immune system, making individuals susceptible to various opportunistic infections and malignancies. The progression of HIV infection is divided into three clinical stages: acute infection, clinical latency, and AIDS. During the acute infection stage, individuals may experience flu-like symptoms. The clinical latency stage, also known as the chronic asymptomatic stage, can last for several years, during which HIV replicates at lower levels. In the final stage, AIDS, severe immune suppression occurs, leading to the development of opportunistic infections and AIDS-defining illnesses. Various diagnostic tests are available to detect HIV infection, including antibody tests, antigen tests, nucleic acid tests, and combination tests. Early detection of HIV is crucial for timely interventions and treatment initiation. Antiretroviral Therapy (ART) is the primary treatment for HIV/AIDS [2].

Literature Review

ART involves the use of a combination of antiretroviral drugs that effectively suppress HIV replication, slow disease progression, and improve the quality of life for people living with HIV/AIDS. Other supportive treatments focus on managing opportunistic infections and associated complications. Prevention plays a pivotal role in curbing the spread of HIV/AIDS. Key prevention strategies include practicing safe sex through the use of condoms, implementing harm reduction programs for injecting drug users, Providing Pre-Exposure Prophylaxis (PREP) to high-risk individuals, promoting voluntary counseling and testing, and eliminating mother-to-child transmission through comprehensive Prevention of Mother-To-Child Transmission (PMTCT) programs. AIDS has had a profound global impact, particularly in sub-Saharan Africa, where the disease burden is disproportionately high. The socio-economic consequences of AIDS are extensive, affecting healthcare systems, families, communities, and economies. Addressing the global impact of AIDS requires concerted efforts in prevention, treatment, and support programs [3].

Ongoing research aims to develop an effective HIV vaccine, improve existing treatment regimens, and explore innovative prevention strategies. International collaborations, increased funding, and strengthening healthcare systems are crucial to achieving the goal of an AIDS-free future. Furthermore, comprehensive sexual education, particularly targeting vulnerable populations such as young people and key populations (e.g., sex workers, men who have sex with men, transgender individuals, and people who inject drugs), is essential in preventing new HIV infections. Promoting condom use, access to clean needles and syringes, and the availability of Pre-Exposure Prophylaxis (PREP) can significantly reduce the risk of HIV transmission. Efforts to eliminate mother-to-child transmission of HIV have shown promising results, but more work is needed to ensure universal access to Prevention of Mother-To-Child Transmission (PMTCT) programs, including antiretroviral drugs for pregnant women living with HIV [4].

Discussion

In terms of research, the development of an effective HIV vaccine remains a top priority. Numerous vaccine candidates have been tested, and while no vaccine has yet proven completely effective, progress continues to be made. Additionally, ongoing research focuses on long-acting antiretroviral drugs, novel treatment strategies, and innovative prevention approaches such as microbicides and HIV prevention implants. Collaboration among governments, healthcare providers, researchers, and community organizations is crucial to addressing the multifaceted challenges posed by AIDS. By strengthening healthcare systems, increasing funding for research and programs, and prioritizing prevention efforts, we can make significant strides in the global response to HIV/AIDS [5,6].

Conclusion

Acquired Immunodeficiency Syndrome (AIDS) remains a critical global health issue, affecting millions of individuals worldwide. Understanding the causes, transmission, symptoms, diagnosis, treatment, and prevention of AIDS is essential for curbing the spread of the disease and improving the quality of life for those affected. By promoting awareness, investing in research, and implementing comprehensive prevention and treatment programs, we can strive towards an AIDS-free world.

Acknowledgment

None.

Conflict of Interest

None.

References

  1. Atwine, Benjamin, Elizabeth Cantor-Graae and Francis Bajunirwe. "Psychological distress among AIDS orphans in rural Uganda." Soc Sci Med 61 (2005): 555-564.
  2. Google Scholar, Crossref, Indexed at

  3. Perry, Elizabeth W., Rachel Culbreth, Monica Swahn and Rogers Kasirye, et al. "Psychological distress among orphaned youth and youth reporting sexual exploitation in Kampala, Uganda." Child Youth Serv Rev 119 (2020): 105587.
  4. Google Scholar, Crossref, Indexed at

  5. Boakye, Dorothy Serwaa and Azwihangwisi Helen Mavhandu-Mudzusi. "Nurses knowledge, attitudes and practices towards patients with HIV and AIDS in Kumasi, Ghana." Int J Afr Nurs Sci 11 (2019): 100147.
  6. Google Scholar, Crossref, Indexed at

  7. Chamie, Gabriel, Sue Napierala, Kawango Agot and Harsha Thirumurthy. "HIV testing approaches to reach the first UNAIDS 95% target in sub-Saharan Africa." Lancet HIV 8 (2021): e225-e236.
  8. Google Scholar, Crossref, Indexed at

  9. Jefferies, Sarah, Nigel French, Charlotte Gilkison and Giles Graham, et al. "COVID-19 in New Zealand and the impact of the national response: A descriptive epidemiological study." Lancet Public Health 5 (2020): e612-e623.
  10. Google Scholar, Crossref, Indexed at

  11. Douthit, Nathan, Sakal Kiv, Tzvi Dwolatzky and Seema Biswas. "Exposing some important barriers to health care access in the rural USA." Public Health 129 (2015): 611-620.
  12. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 2128

Journal of Health & Medical Informatics received 2128 citations as per Google Scholar report

Journal of Health & Medical Informatics peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward